C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 409/10 (2006.01) A61K 31/4025 (2006.01) A61P 1/00 (2006.01)
Patent
CA 2604038
There is provided compounds of formula (I) wherein the dotted line, X1, X2, X3, A, Y1, Y2, Y3, Y4, Z1, Z2, R2 and R3 have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful as selective agonists of the AT2 receptor, and thus, in particular, in the treatment of inter alia gastrointestinal conditions, such as dyspepsia, IBS and MOF, and cardiovascular disorders.
On procure des composés de formule (I) dans laquelle la ligne pointillée, X1, X2, X3, A, Y1, Y2, Y3, Y4, Z1, Z2, R2 et R3 ont les significations données dans la description, et leurs sels acceptables sur le plan pharmaceutique, lesquels composés sont utiles comme agonistes sélectifs du récepteur AT2, et par conséquent, en particulier, dans le traitement des conditions gastro-intestinales notamment, telles que la dyspepsie, l~IBS et le MOF, et des troubles cardiovasculaires.
Alterman Mathias
Hallberg Anders
Wu Xiongyu
Smart & Biggar
Vicore Pharma Ab
LandOfFree
New tricyclic angiotensin ii agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with New tricyclic angiotensin ii agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and New tricyclic angiotensin ii agonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1618017